Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit
MyChart for medical appointments or to contact your provider.
Biography
Ozgur Sahin is an experienced cancer biologist with a strong background in functional genomics, bioinformatics and drug discovery. He discovered the roles of many proteins and non-coding RNAs in the pathogenesis of drug resistant and metastatic cancers. Dr. Sahin is currently a Professor and Endowed Chair in the Department of Biochemistry & Molecular Biology and Hollings Cancer Center (HCC) at Medical University of South Carolina (MUSC), Charleston, SC. He is also the Co-Leader of the Breast Transdisciplinary Cancer Team (TcT) at HCC. Previously, he served as Research Team Leader at German Cancer Research Center (DKFZ), Research Faculty in the Department of Molecular & Cellular Oncology at the University of Texas MD Anderson Cancer Center (MDACC), Assistant Professor in the Department of Molecular Biology & Genetics at Bilkent University and Associate Professor in the Department of Drug Discovery & Biomedical Sciences at the University of South Carolina. To date, Dr. Sahin published more than 70 peer-reviewed papers in the field of cancer research in high impact international journals (e.g. PNAS, Cancer Cell, Nature Communications, Cell Research, Molecular Systems Biology, Cancer Research and Oncogene, etc.) and filed multiple patent applications. To date, he has received multiple funding (as PI) for his research from the National Institutes of Health, American Cancer Society, Department of Defense and different foundations and industry. Dr. Sahin has received many awards, including MUSC Research Excellence Award, USC Research Excellence Award, TUSEB Aziz Sancar (Nobel Laureate) Science Incentive Award from the Health Institutes of Turkey, and Outstanding Young Scientist (GEBIP) Award from Turkish Academy of Sciences.